{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:45:50Z","timestamp":1795085150133,"version":"4.10.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073284"],"award-info":[{"award-number":["82073284"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Sepsis is a global medical issue owing to its unacceptably high mortality rate. Therefore, an effective approach to predicting patient outcomes is critically needed. We aimed to search for a novel 28-day sepsis mortality prediction model based on serial interleukin-6 (IL-6), lactate (LAC), and procalcitonin (PCT) measurements. We enrolled 367 septic patients based on Sepsis-3 (Third International Consensus Definitions for Sepsis and Septic Shock). Serum IL-6, LAC, and PCT levels were measured serially. Results collected within 24 and 48\u201372\u00a0h of admission were marked as D1 and D3 (e.g., IL-6D1\/D3), respectively; the IL-6, LAC, and PCT clearance (IL-6c, LACc, PCTc) at D3 were calculated. Data were split into training and validation cohorts (7:3). Logistic regression analyses were used to select variables to develop models and choose the best one according to the Akaike information criterion (AIC). Receiver operating characteristic curves (ROC), calibration plots, and decision curve analysis (DCA) were used to test model performance. A nomogram was used to validate the model. There were 314 (85.56%) survivors and 53 (14.44%) non-survivors. Logistic regression analyses showed that IL-6D1, IL-6D3, PCTD1, PCTD3, and LACcD3 could be used to develop the best prediction model. The areas under the curves (AUC) of the training (0.849, 95% <jats:italic>CI<\/jats:italic>: 0.787\u20130.911) and validation cohorts (0.828, 95% <jats:italic>CI<\/jats:italic>: 0.727\u20130.929), calibration plot, and the DCA showed that the model performed well. Thus, the predictive value of the risk nomogram was verified. Combining IL-6D1, IL-6D3, PCTD1, PCTD3, and LACcD3 may create an accurate prediction model for 28-day sepsis mortality. Multiple-center research with a larger quantity of data is necessary to determine its clinical utility.<\/jats:p>","DOI":"10.1007\/s10096-022-04517-1","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T13:05:10Z","timestamp":1668603910000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["28-day sepsis mortality prediction model from combined serial interleukin-6, lactate, and procalcitonin measurements: a retrospective cohort study"],"prefix":"10.1007","volume":"42","author":[{"given":"Yinjing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-0671","authenticated-orcid":false,"given":"Weibu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"10219","key":"4517_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease study. The Lancet 395(10219):200\u2013211. https:\/\/doi.org\/10.1016\/s0140-6736(19)32989-7","journal-title":"The Lancet"},{"issue":"8","key":"4517_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"issue":"5","key":"4517_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/CM9.0000000000000101","volume":"132","author":"X Zhou","year":"2019","unstructured":"Zhou X, Su LX, Zhang JH et al (2019) Rules of anti-infection therapy for sepsis and septic shock. Chin Med J (Engl) 132(5):589\u2013596. https:\/\/doi.org\/10.1097\/CM9.0000000000000101","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"4517_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jama.2018.9071","volume":"320","author":"IVR Evans","year":"2018","unstructured":"Evans IVR, Phillips GS, Alpern ER et al (2018) Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis. JAMA 320(4):358\u2013367. https:\/\/doi.org\/10.1001\/jama.2018.9071","journal-title":"JAMA"},{"issue":"1","key":"4517_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12951-021-00959-5","volume":"19","author":"L Liu","year":"2021","unstructured":"Liu L, Han Z, An F et al (2021) Aptamer-based biosensors for the diagnosis of sepsis. J Nanobiotechnol 19(1):216. https:\/\/doi.org\/10.1186\/s12951-021-00959-5","journal-title":"J Nanobiotechnol"},{"issue":"23","key":"4517_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235\u20132244. https:\/\/doi.org\/10.1056\/NEJMoa1703058","journal-title":"N Engl J Med"},{"issue":"1","key":"4517_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12871-020-01203-7","volume":"20","author":"S Czajka","year":"2020","unstructured":"Czajka S, Ziebinska K, Marczenko K et al (2020) Validation of APACHE II, APACHE III and SAPS II scores in in-hospital and one year mortality prediction in a mixed intensive care unit in Poland: a cohort study. BMC Anesthesiol 20(1):296. https:\/\/doi.org\/10.1186\/s12871-020-01203-7","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"4517_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/aas.13536","volume":"64","author":"LEM Haas","year":"2020","unstructured":"Haas LEM, Termorshuizen F, de Lange DW et al (2020) Performance of the quick SOFA in very old ICU patients admitted with sepsis. Acta Anaesthesiol Scand 64(4):508\u2013516. https:\/\/doi.org\/10.1111\/aas.13536","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"4517_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12967-020-02620-5","volume":"18","author":"N Hou","year":"2020","unstructured":"Hou N, Li M, He L et al (2020) Predicting 30-days mortality for MIMIC-III patients with Sepsis-3: a machine learning approach using XGboost. J Transl Med 18(1):462. https:\/\/doi.org\/10.1186\/s12967-020-02620-5","journal-title":"J Transl Med"},{"issue":"1","key":"4517_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12916-020-01546-5","volume":"18","author":"J Wang","year":"2020","unstructured":"Wang J, Sun Y, Teng S et al (2020) Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation. BMC Med 18(1):83. https:\/\/doi.org\/10.1186\/s12916-020-01546-5","journal-title":"BMC Med"},{"issue":"2","key":"4517_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jclinepi.2014.11.010","volume":"68","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. J Clin Epidemiol 68(2):134\u2013143. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.11.010","journal-title":"J Clin Epidemiol"},{"key":"4517_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2147\/JIR.S302975","volume":"14","author":"L Li","year":"2021","unstructured":"Li L, Chen L, Lin F et al (2021) Study of the expression of inflammatory factors IL-4, IL-6, IL-10, and IL-17 in liver failure complicated by coagulation dysfunction and sepsis. J Inflamm Res 14:1447\u20131453. https:\/\/doi.org\/10.2147\/JIR.S302975","journal-title":"J Inflamm Res"},{"key":"4517_CR13","doi-asserted-by":"publisher","first-page":"8201585","DOI":"10.1155\/2020\/8201585","volume":"2020","author":"B Smok","year":"2020","unstructured":"Smok B, Domagalski K, Pawlowska M (2020) Diagnostic and prognostic value of IL-6 and sTREM-1 in SIRS and sepsis in children. Mediators Inflamm 2020:8201585. https:\/\/doi.org\/10.1155\/2020\/8201585","journal-title":"Mediators Inflamm"},{"key":"4517_CR14","doi-asserted-by":"publisher","unstructured":"Hung SK, Lan HM, Han ST et al (2020) Current Evidence and Limitation of Biomarkers for Detecting Sepsis and Systemic Infection. Biomed 8(11) https:\/\/doi.org\/10.3390\/biomedicines8110494","DOI":"10.3390\/biomedicines8110494"},{"issue":"4","key":"4517_CR15","doi-asserted-by":"publisher","first-page":"e0175254","DOI":"10.1371\/journal.pone.0175254","volume":"12","author":"JJ Rios-Toro","year":"2017","unstructured":"Rios-Toro JJ, Marquez-Coello M, Garcia-Alvarez JM et al (2017) Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. PLoS One 12(4):e0175254. https:\/\/doi.org\/10.1371\/journal.pone.0175254","journal-title":"PLoS One"},{"issue":"1","key":"4517_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12879-019-4618-7","volume":"19","author":"J Song","year":"2019","unstructured":"Song J, Park DW, Moon S et al (2019) Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis 19(1):968. https:\/\/doi.org\/10.1186\/s12879-019-4618-7","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4517_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.medin.2012.01.014","volume":"36","author":"V Miguel-Bayarri","year":"2012","unstructured":"Miguel-Bayarri V, Casanoves-Laparra EB, Pallas-Beneyto L et al (2012) Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva 36(8):556\u2013562. https:\/\/doi.org\/10.1016\/j.medin.2012.01.014","journal-title":"Med Intensiva"},{"issue":"3","key":"4517_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/SHK.0000000000000616","volume":"46","author":"W Takahashi","year":"2016","unstructured":"Takahashi W, Nakada TA, Yazaki M et al (2016) Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units. Shock 46(3):254\u2013260. https:\/\/doi.org\/10.1097\/SHK.0000000000000616","journal-title":"Shock"},{"issue":"7678","key":"4517_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, Ghergurovich JM, Morscher RJ et al (2017) Glucose feeds the TCA cycle via circulating lactate. Nature 551(7678):115\u2013118. https:\/\/doi.org\/10.1038\/nature24057","journal-title":"Nature"},{"issue":"7","key":"4517_CR20","doi-asserted-by":"publisher","first-page":"e24835","DOI":"10.1097\/MD.0000000000024835","volume":"100","author":"SG Lee","year":"2021","unstructured":"Lee SG, Song J, Park DW et al (2021) Prognostic value of lactate levels and lactate clearance in sepsis and septic shock with initial hyperlactatemia: a retrospective cohort study according to the Sepsis-3 definitions. Med (Baltimore) 100(7):e24835. https:\/\/doi.org\/10.1097\/MD.0000000000024835","journal-title":"Med (Baltimore)"},{"issue":"8","key":"4517_CR21","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s11739-019-02196-z","volume":"14","author":"F Innocenti","year":"2019","unstructured":"Innocenti F, Meo F, Giacomelli I et al (2019) Prognostic value of serial lactate levels in septic patients with and without shock. Intern Emerg Med 14(8):1321\u20131330. https:\/\/doi.org\/10.1007\/s11739-019-02196-z","journal-title":"Intern Emerg Med"},{"issue":"6","key":"4517_CR22","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1097\/CCM.0000000000003030","volume":"46","author":"SM Ryoo","year":"2018","unstructured":"Ryoo SM, Lee J, Lee YS et al (2018) Lactate level versus lactate clearance for predicting mortality in patients with septic shock defined by Sepsis-3. Crit Care Med 46(6):e489\u2013e495. https:\/\/doi.org\/10.1097\/CCM.0000000000003030","journal-title":"Crit Care Med"},{"issue":"11","key":"4517_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181\u20131247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"issue":"1","key":"4517_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccc.2019.08.003","volume":"36","author":"B Hamade","year":"2020","unstructured":"Hamade B, Huang DT (2020) Procalcitonin: where are we now? Crit Care Clin 36(1):23\u201340. https:\/\/doi.org\/10.1016\/j.ccc.2019.08.003","journal-title":"Crit Care Clin"},{"key":"4517_CR25","doi-asserted-by":"publisher","first-page":"819034","DOI":"10.1155\/2014\/819034","volume":"2014","author":"MB Mat Nor","year":"2014","unstructured":"Mat Nor MB, Md Ralib A (2014) Procalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis. Crit Care Res Pract 2014:819034. https:\/\/doi.org\/10.1155\/2014\/819034","journal-title":"Crit Care Res Pract"},{"key":"4517_CR26","doi-asserted-by":"publisher","first-page":"1758501","DOI":"10.1155\/2016\/1758501","volume":"2016","author":"MY Huang","year":"2016","unstructured":"Huang MY, Chen CY, Chien JH et al (2016) Serum procalcitonin and procalcitonin clearance as a prognostic biomarker in patients with severe sepsis and septic shock. Biomed Res Int 2016:1758501. https:\/\/doi.org\/10.1155\/2016\/1758501","journal-title":"Biomed Res Int"},{"issue":"12","key":"4517_CR27","doi-asserted-by":"publisher","first-page":"e0145181","DOI":"10.1371\/journal.pone.0145181","volume":"10","author":"SM Lee","year":"2015","unstructured":"Lee SM, Kim SE, Kim EB et al (2015) Lactate clearance and vasopressor seem to be predictors for mortality in severe sepsis patients with lactic acidosis supplementing sodium bicarbonate: a retrospective analysis. PLoS One 10(12):e0145181. https:\/\/doi.org\/10.1371\/journal.pone.0145181","journal-title":"PLoS One"},{"issue":"1","key":"4517_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12891-020-03283-5","volume":"21","author":"ZY Huang","year":"2020","unstructured":"Huang ZY, Huang Q, Wang LY et al (2020) Normal trajectory of interleukin-6 and C-reactive protein in the perioperative period of total knee arthroplasty under an enhanced recovery after surgery scenario. BMC Musculoskelet Disord 21(1):264. https:\/\/doi.org\/10.1186\/s12891-020-03283-5","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"4517_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1177\/0885066619861588","volume":"35","author":"AP Nassar Jr","year":"2020","unstructured":"Nassar AP Jr, Nassif BN, Santos D et al (2020) Procalcitonin clearance at 24, 48, 72, and 96 hours and mortality in patients with cancer and sepsis: a retrospective cohort study. J Intensive Care Med 35(11):1297\u20131301. https:\/\/doi.org\/10.1177\/0885066619861588","journal-title":"J Intensive Care Med"},{"issue":"5","key":"4517_CR30","first-page":"399","volume":"49","author":"JP Sikora","year":"2001","unstructured":"Sikora JP, Chlebna-Sokol D, Krzyzanska-Oberbek A (2001) Proinflammatory cytokines (IL-6, IL-8), cytokine inhibitors (IL-6sR, sTNFRII) and anti-inflammatory cytokines (IL-10, IL-13) in the pathogenesis of sepsis in newborns and infants. Arch Immunol Ther Exp (Warsz) 49(5):399\u2013404","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"4517_CR31","doi-asserted-by":"publisher","first-page":"e929527","DOI":"10.12659\/MSM.929527","volume":"27","author":"Y Xie","year":"2021","unstructured":"Xie Y, Li B, Lin Y et al (2021) Combining blood-based biomarkers to predict mortality of sepsis at arrival at the Emergency Department. Med Sci Monit 27:e929527. https:\/\/doi.org\/10.12659\/MSM.929527","journal-title":"Med Sci Monit"},{"issue":"1","key":"4517_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcrc.2010.04.011","volume":"26","author":"K Tschaikowsky","year":"2011","unstructured":"Tschaikowsky K, Hedwig-Geissing M, Braun GG et al (2011) Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 26(1):54\u201364. https:\/\/doi.org\/10.1016\/j.jcrc.2010.04.011","journal-title":"J Crit Care"},{"issue":"5","key":"4517_CR33","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1182\/blood.V74.5.1704.1704","volume":"74","author":"CE Hack","year":"1989","unstructured":"Hack CE, De Groot ER, Felt-Bersma RJ et al (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74(5):1704\u20131710","journal-title":"Blood"},{"issue":"8","key":"4517_CR34","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s001340050425","volume":"23","author":"A Sander","year":"1997","unstructured":"Sander A, Armbruster W, Sander B et al (1997) Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23(8):878\u2013884. https:\/\/doi.org\/10.1007\/s001340050425","journal-title":"Intensive Care Med"},{"issue":"24","key":"4517_CR35","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1056\/NEJMra1309483","volume":"371","author":"JA Kraut","year":"2014","unstructured":"Kraut JA, Madias NE (2014) Lactic acidosis. N Engl J Med 371(24):2309\u20132319. https:\/\/doi.org\/10.1056\/NEJMra1309483","journal-title":"N Engl J Med"},{"issue":"8","key":"4517_CR36","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/01.ccm.0000132904.35713.a7","volume":"32","author":"HB Nguyen","year":"2004","unstructured":"Nguyen HB, Rivers EP, Knoblich BP et al (2004) Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32(8):1637\u20131642. https:\/\/doi.org\/10.1097\/01.ccm.0000132904.35713.a7","journal-title":"Crit Care Med"},{"issue":"3","key":"4517_CR37","doi-asserted-by":"publisher","first-page":"e0087","DOI":"10.1097\/CCE.0000000000000087","volume":"2","author":"M Baysan","year":"2020","unstructured":"Baysan M, Baroni GD, van Boekel AM et al (2020) The added value of lactate and lactate clearance in prediction of in-hospital mortality in critically ill patients with sepsis. Crit Care Explor 2(3):e0087. https:\/\/doi.org\/10.1097\/CCE.0000000000000087","journal-title":"Crit Care Explor"},{"issue":"1","key":"4517_CR38","doi-asserted-by":"publisher","first-page":"22394","DOI":"10.1038\/s41598-021-01856-5","volume":"11","author":"M Sugimoto","year":"2021","unstructured":"Sugimoto M, Takayama W, Murata K et al (2021) The impact of lactate clearance on outcomes according to infection sites in patients with sepsis: a retrospective observational study. Sci Rep 11(1):22394. https:\/\/doi.org\/10.1038\/s41598-021-01856-5","journal-title":"Sci Rep"},{"issue":"1","key":"4517_CR39","doi-asserted-by":"publisher","first-page":"20076","DOI":"10.1038\/s41598-021-99581-6","volume":"11","author":"CM Sauer","year":"2021","unstructured":"Sauer CM, Gomez J, Botella MR et al (2021) Understanding critically ill sepsis patients with normal serum lactate levels: results from U.S. and European ICU cohorts. Sci Rep 11(1):20076. https:\/\/doi.org\/10.1038\/s41598-021-99581-6","journal-title":"Sci Rep"},{"issue":"8844","key":"4517_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-n","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H et al (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515\u2013518. https:\/\/doi.org\/10.1016\/0140-6736(93)90277-n","journal-title":"Lancet"},{"issue":"7","key":"4517_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.medin.2011.11.024","volume":"36","author":"JC Ruiz-Rodriguez","year":"2012","unstructured":"Ruiz-Rodriguez JC, Caballero J, Ruiz-Sanmartin A et al (2012) Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. Prospect Pilot Study Med Intensiva 36(7):475\u2013480. https:\/\/doi.org\/10.1016\/j.medin.2011.11.024","journal-title":"Prospect Pilot Study Med Intensiva"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04517-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T03:05:28Z","timestamp":1673233528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04517-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["4517"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04517-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the hospital ethics committee (no. KY-LL\u20132020157\u201302).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}